Annual CFO
-$144.03 M
+$249.24 M+63.38%
December 31, 2024
Summary
- As of March 13, 2025, LEGN annual cash flow from operations is -$144.03 million, with the most recent change of +$249.24 million (+63.38%) on December 31, 2024.
- During the last 3 years, LEGN annual CFO has risen by +$54.43 million (+27.43%).
- LEGN annual CFO is now -146.81% below its all-time high of $307.68 million, reached on December 31, 2018.
Performance
LEGN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$82.08 M
-$6.26 M-8.25%
December 31, 2024
Summary
- As of March 13, 2025, LEGN quarterly cash flow from operations is -$82.08 million, with the most recent change of -$6.26 million (-8.25%) on December 31, 2024.
- Over the past year, LEGN quarterly CFO has increased by +$13.57 million (+14.18%).
- LEGN quarterly CFO is now -511.48% below its all-time high of $19.95 million, reached on September 30, 2019.
Performance
LEGN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$144.03 M
+$13.57 M+8.61%
December 31, 2024
Summary
- As of March 13, 2025, LEGN TTM cash flow from operations is -$144.03 million, with the most recent change of +$13.57 million (+8.61%) on December 31, 2024.
- Over the past year, LEGN TTM CFO has increased by +$249.24 million (+63.38%).
- LEGN TTM CFO is now -3281.85% below its all-time high of -$4.26 million, reached on March 31, 2019.
Performance
LEGN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
LEGN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +63.4% | +14.2% | +63.4% |
| 3 y3 years | +27.4% | +14.2% | +63.4% |
| 5 y5 years | -73.4% | +14.2% | +63.4% |
LEGN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +63.4% | -628.9% | +41.0% | -1.0% | +63.4% |
| 5 y | 5-year | -73.4% | +63.4% | -628.9% | +41.0% | -73.4% | +63.4% |
| alltime | all time | -146.8% | +63.4% | -511.5% | +41.0% | -3281.8% | +63.4% |
Legend Biotech Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$144.03 M(-63.4%) | -$82.08 M(+8.3%) | -$144.03 M(-8.6%) |
| Sep 2024 | - | -$75.82 M(+4492.5%) | -$157.60 M(+10.5%) |
| Jun 2024 | - | -$1.65 M(-110.6%) | -$142.63 M(-40.2%) |
| Mar 2024 | - | $15.52 M(-116.2%) | -$238.54 M(-39.3%) |
| Dec 2023 | -$393.28 M(+95.4%) | -$95.64 M(+57.2%) | -$393.28 M(+13.2%) |
| Sep 2023 | - | -$60.85 M(-37.6%) | -$347.37 M(-3.1%) |
| Jun 2023 | - | -$97.57 M(-29.9%) | -$358.64 M(+37.0%) |
| Mar 2023 | - | -$139.22 M(+179.9%) | -$261.81 M(+30.1%) |
| Dec 2022 | -$201.28 M(+1.4%) | -$49.74 M(-31.0%) | -$201.28 M(-9.0%) |
| Sep 2022 | - | -$72.11 M(+9644.9%) | -$221.09 M(+14.2%) |
| Jun 2022 | - | -$740.00 K(-99.1%) | -$193.57 M(-22.7%) |
| Mar 2022 | - | -$78.69 M(+13.1%) | -$250.37 M(+26.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$198.47 M(-11.0%) | -$69.55 M(+56.0%) | -$198.47 M(+7.4%) |
| Sep 2021 | - | -$44.59 M(-22.5%) | -$184.87 M(-9.7%) |
| Jun 2021 | - | -$57.54 M(+114.8%) | -$204.65 M(+0.3%) |
| Mar 2021 | - | -$26.79 M(-52.1%) | -$204.00 M(-8.5%) |
| Dec 2020 | -$223.00 M(+168.5%) | -$55.95 M(-13.1%) | -$223.00 M(-1.8%) |
| Sep 2020 | - | -$64.37 M(+13.2%) | -$227.04 M(+59.1%) |
| Jun 2020 | - | -$56.88 M(+24.2%) | -$142.72 M(+14.5%) |
| Mar 2020 | - | -$45.80 M(-23.7%) | -$124.60 M(+50.0%) |
| Dec 2019 | -$83.06 M(-127.0%) | -$59.99 M(-400.7%) | -$83.06 M(+259.9%) |
| Sep 2019 | - | $19.95 M(-151.5%) | -$23.08 M(-46.4%) |
| Jun 2019 | - | -$38.77 M(+810.2%) | -$43.02 M(+910.2%) |
| Mar 2019 | - | -$4.26 M | -$4.26 M |
| Dec 2018 | $307.68 M | - | - |
FAQ
- What is Legend Biotech annual cash flow from operations?
- What is the all time high annual CFO for Legend Biotech?
- What is Legend Biotech annual CFO year-on-year change?
- What is Legend Biotech quarterly cash flow from operations?
- What is the all time high quarterly CFO for Legend Biotech?
- What is Legend Biotech quarterly CFO year-on-year change?
- What is Legend Biotech TTM cash flow from operations?
- What is the all time high TTM CFO for Legend Biotech?
- What is Legend Biotech TTM CFO year-on-year change?
What is Legend Biotech annual cash flow from operations?
The current annual CFO of LEGN is -$144.03 M
What is the all time high annual CFO for Legend Biotech?
Legend Biotech all-time high annual cash flow from operations is $307.68 M
What is Legend Biotech annual CFO year-on-year change?
Over the past year, LEGN annual cash flow from operations has changed by +$249.24 M (+63.38%)
What is Legend Biotech quarterly cash flow from operations?
The current quarterly CFO of LEGN is -$82.08 M
What is the all time high quarterly CFO for Legend Biotech?
Legend Biotech all-time high quarterly cash flow from operations is $19.95 M
What is Legend Biotech quarterly CFO year-on-year change?
Over the past year, LEGN quarterly cash flow from operations has changed by +$13.57 M (+14.18%)
What is Legend Biotech TTM cash flow from operations?
The current TTM CFO of LEGN is -$144.03 M
What is the all time high TTM CFO for Legend Biotech?
Legend Biotech all-time high TTM cash flow from operations is -$4.26 M
What is Legend Biotech TTM CFO year-on-year change?
Over the past year, LEGN TTM cash flow from operations has changed by +$249.24 M (+63.38%)